China Longevity Group Company Limited (stock name: CHI LONGEVITY) reported no changes to its share structure for the month ended 31 August 2026, according to the company’s monthly return filed with Hong Kong Exchanges and Clearing Limited on 1 September 2026.

The authorised share capital stayed flat at 2.00 million ordinary shares with a par value of HKD 0.001 each, preserving the total authorised capital at HKD 2.00 million.

Issued share capital was likewise unchanged. The company closed August with 852.61 million ordinary shares in issue and no treasury shares on its books, identical to the previous month’s balance.

No activity was recorded under share option schemes, warrants, convertible securities, or other share-related agreements, indicating an absence of equity dilution events during the reporting period.

Management confirmed that China Longevity continues to meet the Main Board’s minimum public float requirement, maintaining at least 25% of its issued share capital in public hands.

The filing was authorised and submitted by Company Secretary Joseph Chow, affirming compliance with all applicable listing rules and regulatory obligations.